Corza Medical Announces the Launch of the Expanded Onatec Ophthalmic Suture Portfolio

Corza Medical has officially expanded its Onatec Ophthalmic Suture Portfolio, adding nearly 130 specialized products designed exclusively for ophthalmic and oculoplastic surgery.

Corza Medical, a leading global medical technology company, announced the launch of its expanded Onatec Ophthalmic Suture Portfolio. This marks an important extension of the product range, making it simple for surgeons worldwide to find the right Onatec suture services for their ophthalmic procedures.

The nearly 130 products in the suture portfolio are intended solely for ophthalmic and oculoplastic surgery and include a full spectrum of absorbable and non-absorbable sutures. These additions reinforce Corza Medical’s position as an intended partner in ophthalmic innovation, providing solutions tailored to the emerging needs of surgeons globally.

Along with the line of sutures are Onatec Needles, which are crafted from premium, high-grade tempered stainless steel. Each needle offers exceptional resistance to bending and breakage. The precise, automated manufacturing results in optimal needle geometry and grind accuracy, allowing suturing of the most delicate tissues. Paired together, the suture and needle supply advanced tactile feedback and improve control with each pass, which are qualities significant to delicate ophthalmic surgery.

“Our ophthalmic sutures, instruments, plugs, devices, and biologics exemplify precision and craftsmanship,” said Jack Simmons, president, Medical Devices at Corza Medical. “With the expansion of Onatec ophthalmic sutures, Corza Medical continues to lead in providing procedure-relevant solutions. We are proud to be the only company offering a dedicated ophthalmic suture portfolio that serves every stage of the surgical journey, from cut to close.”

The organization added that in addition to its line of suture products, there are its Onatec needles, made from premium and extremely hardened stainless steel. Every needle offers flexural and breaking strength. Corza Medical said, “Rigorous, automated manufacturing ensures optimal needle geometry and accurate grinding, creating it easy to suture even the most delicate tissues. Used together, the suture and needle provide a better tactile feel and control with each stroke, which is essential for sensitive ophthalmological procedures.”

According to Towards Healthcare, the synthetic absorbable sutures market is projected to grow significantly, with estimates indicating the market size will increase from USD 3.18 billion in 2026 to approximately USD 6.54 billion by 2035, expanding at a CAGR of 8.34% from 2026 to 2035. Absorbable sutures are contained in the group of surgical sutures that deteriorate over time and lose their tensile strength. These sutures are applied in tissue approximations and are frequently used in internal tissues and during the healing process. They are assessed by their sensitivity to moisture and tensile strength. Synthetic absorbable sutures are hydrolyzed by tissue fluids secreted from the lungs or kidneys. Furthermore, the hydrolysis process is an organic chemical reaction in which water is used to break down some of the molecules. It causes less tissue reaction than enzymatic effects. Absorbable sutures with PDO structure are sterile surgical sutures for longer wound closure than other absorbable sutures. PDO-structured absorbable suture has amplified tensile strength in a biological environment.

About Corza Medical

Corza Medical is a leading worldwide healthcare technology organization that specializes in innovative surgical services and technologies. With a worldwide team of approximately 3,000 employees helping doctors, distributor partners, and medical healthcare companies worldwide, Corza provides healthcare professionals with a platform of surgical technologies featuring major industry-leading brands, involving Quill barbed sutures, Sharpoint Plus and Look surgical sutures, Katena reusable and Blink single-use ophthalmic instruments, Barron corneal transplant devices, Sharpoint® microsurgical knives, and the TachoSil fibrin sealant patch.

A recent report by Towards Healthcare highlights that the synthetic absorbable sutures market is growing, as synthetic absorbable sutures are often selected for closing layers in abdominal, gynecological, and urological surgeries. A significant benefit in these regions is the elimination of the requirement for later removal, which is impractical in body cavities. The material offers adequate tension while the initial healing phase, after which it undergoes hydrolysis. Pediatric surgery significantly employs a synthetic absorbable suture to prevent the distress and procedural load of suture removal in young patients. The predictable absorption rate and reduced tissue reactivity are consistent factors increasing their selection in these diverse specialties.